CVR number 40641947
Industry 47.9113 Retail sale via mail order houses or via Internet

MelaMedic ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
2020/9
2021
2021/9
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  4.1% 4.1% 4.1% 4.1% 4.1%  
Bankruptcy risk  0.0% 4.8% 2.9% 9.3% 3.4%  
Credit score (0-100)  0 45 56 26 53  
Credit rating  N/A BBB BBB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/9
2021
2021/9
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  0.0 398 560 -55.0 154  
EBITDA  0.0 208 300 58.8 101  
EBIT  0.0 198 291 52.5 101  
Pre-tax profit (PTP)  0.0 196.9 289.2 -232.8 98.8  
Net earnings  0.0 153.6 225.6 -235.6 98.8  
Pre-tax profit without non-rec. items  0.0 197 289 47.3 98.8  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/9
2021
2021/9
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 192 417 219 318  
Interest-bearing liabilities  0.0 0.0 0.0 0.2 0.0  
Balance sheet total (assets)  0.0 479 653 402 383  
Net Debt  0.0 -150 -160 -115 -64.8  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/9
2021
2021/9
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 398 560 -55.0 154  
Gross profit growth  0.0% 0.0% 40.7% 0.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 479 653 402 383  
Balance sheet change%  0.0% 0.0% 36.3% -38.4% -4.8%  
Added value  0.0 208.1 299.8 60.9 101.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 4 -17 -13 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 4.0  

Profitability 
2019
N/A
2020
2020/9
2021
2021/9
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 49.7% 52.1% -95.5% 65.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 41.3% 51.5% 10.0% 25.7%  
ROI %  0.0% 84.1% 81.0% 14.9% 37.6%  
ROE %  0.0% 80.0% 74.0% -74.0% 36.8%  

Solidity 
2019
N/A
2020
2020/9
2021
2021/9
2022
2023/6
2023
2024/6
Equity ratio %  0.0% 40.1% 63.9% 54.5% 83.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -71.9% -53.4% -196.2% -64.1%  
Gearing %  0.0% 0.0% 0.0% 0.1% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 5,958.9% 2,528.0%  

Liquidity 
2019
N/A
2020
2020/9
2021
2021/9
2022
2023/6
2023
2024/6
Quick Ratio  0.0 1.3 2.1 0.7 1.4  
Current Ratio  0.0 1.9 3.8 2.2 5.9  
Cash and cash equivalent  0.0 149.7 160.2 115.5 64.8  

Capital use efficiency 
2019
N/A
2020
2020/9
2021
2021/9
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 219.3 476.7 217.6 316.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/9
2021
2021/9
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0